Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (221-230 of 299) with videos related to

Pageof 30
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplantSonali M Smith, Koen van Besien, Jeanette Carreras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximabJaveed Iqbal, Paul N Meyer, Lynette M Smith, et al.
British Journal of Haematology|April 20, 2018
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project NetworkMassimo Federico, Monica Bellei, Luigi Marcheselli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphomaJaveed Iqbal, Vishala T Neppalli, George Wright, et al.
Blood Advances|January 4, 2018
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HLMonika Pilichowska, Stefania Pittaluga, Judith A Ferry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments ReceivedLowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
British Journal of Haematology|July 30, 2016
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiableDaniel J Landsburg, Marissa K Falkiewicz, Adam M Petrich, et al.
British Journal of Haematology|September 28, 2021
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantationPeter A Riedell, Mehdi Hamadani, Kwang W Ahn, et al.
Hematological Oncology|July 17, 2010
Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcomeEkaterina Chigrinova, Michael Mian, Marta Scandurra, et al.
Blood|June 29, 2012
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphomaAnamarija M Perry, Teresa M Cardesa-Salzmann, Paul N Meyer, et al.
Pageof 30

Showing results (221-230 of 299) with videos related to

Sort By:
Pageof 30
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplantSonali M Smith, Koen van Besien, Jeanette Carreras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximabJaveed Iqbal, Paul N Meyer, Lynette M Smith, et al.
British Journal of Haematology|April 20, 2018
Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project NetworkMassimo Federico, Monica Bellei, Luigi Marcheselli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2006
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphomaJaveed Iqbal, Vishala T Neppalli, George Wright, et al.
Blood Advances|January 4, 2018
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HLMonika Pilichowska, Stefania Pittaluga, Judith A Ferry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2016
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments ReceivedLowell E Schnipper, Nancy E Davidson, Dana S Wollins, et al.
British Journal of Haematology|July 30, 2016
Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiableDaniel J Landsburg, Marissa K Falkiewicz, Adam M Petrich, et al.
British Journal of Haematology|September 28, 2021
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantationPeter A Riedell, Mehdi Hamadani, Kwang W Ahn, et al.
Hematological Oncology|July 17, 2010
Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcomeEkaterina Chigrinova, Michael Mian, Marta Scandurra, et al.
Blood|June 29, 2012
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphomaAnamarija M Perry, Teresa M Cardesa-Salzmann, Paul N Meyer, et al.
Pageof 30